| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/2004 | EP1429717A1 Topical compositions containing fluid-absorbent solids and adhesive fluids |
| 06/23/2004 | EP1429713A2 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 06/23/2004 | EP1429712A2 Method for treating bronchial constriction and bronchospasm |
| 06/23/2004 | EP1429629A1 Compositions for appetite control and related methods |
| 06/23/2004 | EP1429628A1 Mixture of base-containing micronutrient substances |
| 06/23/2004 | EP1372392A4 Nicotine-containing oral dosage form |
| 06/23/2004 | EP1353906B1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 06/23/2004 | EP1274698B1 Percyquinnin, a process for its production and its use as a pharmaceutical |
| 06/23/2004 | EP1255753B1 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1251848B1 Gyrase inhibitors and uses thereof |
| 06/23/2004 | EP1246817B1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 06/23/2004 | EP1239832B1 Suspension comprising oxcarbazepine |
| 06/23/2004 | EP1237851A4 SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP1214061B1 Use of docetaxel for treating hepatocellular carcinoma |
| 06/23/2004 | EP1214040A4 Extracts of orange peel for prevention and treatment of cancer |
| 06/23/2004 | EP1210347B1 Carbocyclic nucleosides and process for obtaining such |
| 06/23/2004 | EP1206244B1 Aqueous pharmaceutical composition containing moxifloxacin or salts thereof |
| 06/23/2004 | EP1189620B1 Formulation comprising testosteron undecanoate and castor oil |
| 06/23/2004 | EP1171146B1 Pharmaceutical compositions containing selegiline and ginkgo biloba extract useful for treating dementia |
| 06/23/2004 | EP1165508B1 Anticancer calcium channel blockers |
| 06/23/2004 | EP1140108B1 Method and composition for treatment of female sexual dysfunction |
| 06/23/2004 | EP1124556B1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders |
| 06/23/2004 | EP1107763B1 Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug |
| 06/23/2004 | EP1076644B1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 06/23/2004 | EP1071427B1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 06/23/2004 | EP1066283B1 Substituted indolealkanoic acids |
| 06/23/2004 | EP1036075B1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties |
| 06/23/2004 | EP1024801B1 Method for regulating size and growth of vascularized normal tissue |
| 06/23/2004 | EP1017404B1 Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 06/23/2004 | EP1009398A4 Molecular complex and control-release of alpha hydroxyacids |
| 06/23/2004 | EP1007045B1 Topical application of opioid analgesic drugs such as morphine |
| 06/23/2004 | EP1003500A4 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| 06/23/2004 | EP0999839B1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 06/23/2004 | EP0983251B1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 06/23/2004 | EP0980359B1 Benzimidazole derivative |
| 06/23/2004 | EP0977576B1 Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s |
| 06/23/2004 | EP0973516B1 Use of halo and/or nitro-substituted flavonoids as anxyolitics |
| 06/23/2004 | EP0966424B1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 06/23/2004 | EP0930886B1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 06/23/2004 | EP0906340B1 Purification of factor viii complex by immunoaffinity chromatography |
| 06/23/2004 | EP0871471B1 Compositions using morphogenic proteins and stimulatory factors |
| 06/23/2004 | EP0850048B1 Pharmaceutical granules |
| 06/23/2004 | EP0779889B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 06/23/2004 | EP0754069B1 Treatment of pulmonary vasoconstriction and asthma |
| 06/23/2004 | EP0750505B1 Immunotherapy of cancer with allogeneic lymphocytes |
| 06/23/2004 | CN1507456A Fibre containing composition for enteral nutrition |
| 06/23/2004 | CN1507455A Food product with prolonged energy release |
| 06/23/2004 | CN1507452A Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/23/2004 | CN1507450A Novel cyclo azaphospha hydrocarbons |
| 06/23/2004 | CN1507449A 1-oxa-3,9-diaza-spiro [5,5] undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 06/23/2004 | CN1507448A N-But-3-Enyl norbuprenophine and its use as analgesic |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1507446A Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 06/23/2004 | CN1507445A Chromenylmethyl pyrimidinediamines as antibacterial agents |
| 06/23/2004 | CN1507444A 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 06/23/2004 | CN1507442A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 06/23/2004 | CN1507441A Tricyclic alkylhydroxamates, their preparation and thier use as well proliferation inhibitors |
| 06/23/2004 | CN1507437A Aralkylpiperazines with serotonin 5-HTIA activity |
| 06/23/2004 | CN1507436A Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 06/23/2004 | CN1507435A Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507429A Extract from the pods of lupin seeds containing lupeol |
| 06/23/2004 | CN1507365A Formation of small crystals |
| 06/23/2004 | CN1507356A Remedies for sepsis |
| 06/23/2004 | CN1507355A Combination therapy using anti-EGFR antibodies and anti-hormonal agents |
| 06/23/2004 | CN1507354A Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 06/23/2004 | CN1507351A Treatment of ADHD |
| 06/23/2004 | CN1507350A N-acetylcysteine compositions and methods for the treatment and preventino of drug toxicity |
| 06/23/2004 | CN1507349A Medicaments containing a polyamine as an active substance |
| 06/23/2004 | CN1507348A Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| 06/23/2004 | CN1507347A Coated granules based on angiotensin-converting enzyme inhibitor |
| 06/23/2004 | CN1507345A Method to prepare microparticles metoprolol that contain |
| 06/23/2004 | CN1507344A Method to obtain microparticles containing a H*, K*-ATP enzyme inhibitor |
| 06/23/2004 | CN1507343A Method to obtain microparticle containing a H*, K*-ATP-enzyme inhibitor |
| 06/23/2004 | CN1507320A Antimicrobial formulations |
| 06/23/2004 | CN1506373A Composition, extraction process and use of total triterpene sapogenin extracted from bamboo |
| 06/23/2004 | CN1506371A New crystalline Idedate and its composition |
| 06/23/2004 | CN1506364A Optically pure S-(-)-and R-(+)- Omeprazole prepn and the prepn process |
| 06/23/2004 | CN1506363A Photoactive dicyclic alcohol and its prepn, medicinal composition and use |
| 06/23/2004 | CN1506355A Diphenyl benzimidazole compound containing sulfonyl group and its prepn process, medicinal composition and use |
| 06/23/2004 | CN1506117A Antitumor genetic transcription regulating medicine |
| 06/23/2004 | CN1506095A Cold-treating medicine containing Dexamethasone acetate |
| 06/23/2004 | CN1506088A Cold-treating medicine containing chlorpheniramine |
| 06/23/2004 | CN1506075A Cell growth regulating factor V and its prepn process |
| 06/23/2004 | CN1506073A Application of zinc salt in medicine for treating diabetes |
| 06/23/2004 | CN1506072A Lecithin-containing drinking water for children |
| 06/23/2004 | CN1506069A Weixitie-containing drinking water for children |
| 06/23/2004 | CN1506068A Calcium-containing drinking water for children |
| 06/23/2004 | CN1506067A Application of chitin oligose in anticancer drug |
| 06/23/2004 | CN1506066A Cell growth regulating factor oral liquid and its prepn process |
| 06/23/2004 | CN1506065A Cell growth regulating factor D and its prepn process |
| 06/23/2004 | CN1506064A Cell growth regulating factor E and its prepn process |
| 06/23/2004 | CN1506063A Cell growth regulatnig factor F and its prepn process |
| 06/23/2004 | CN1506062A Cell growth regulating factor G and its prepn process |
| 06/23/2004 | CN1506061A Cell growth regulating factor II and its prepn process |
| 06/23/2004 | CN1506060A Cell growth regulating factor I and its prepn process |
| 06/23/2004 | CN1506059A Cell growth regulating factor K and its prepn process |
| 06/23/2004 | CN1506058A Cell growth regulating factor O and its prepn process |